Table 1 Demographic characteristics of Multiple Sclerosis patients.
From: Toxoplasma gondii and multiple sclerosis: a population-based case–control study
Multiple Sclerosis patients (n = 129) | |
|---|---|
Age, y (mean ± SD) | 44.7 ± 11.0 |
Sex (women), n (%) | 86 (66.7) |
Age at onset, y (mean ± SD) | 32.7 ± 11.3 |
Disease duration, y (mean ± SD) | 12.0 ± 8.2 |
Disease type, n (%) | |
Relapsing Remitting | 103 (79.8) |
Secondary Progressive | 23 (17.0) |
Primary Progressive | 2 (1.5) |
Other | 2 (1.5) |
EDSS, mean ± SD | 2.5 ± 2.2 |
Treatment, n (%) | |
No therapy | 17 (13.4) |
Immunomodulators | 76 (59.8) |
Immunosuppressants | 20 (15.7) |
Monoclonal antibodies | 14 (11.0) |
T. gondii seropositivity, n (%) | 38 (29.5) |
